2005
DOI: 10.1016/j.ijcard.2004.12.041
|View full text |Cite
|
Sign up to set email alerts
|

Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
101
1
2

Year Published

2009
2009
2020
2020

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 131 publications
(108 citation statements)
references
References 29 publications
4
101
1
2
Order By: Relevance
“…[3][4][5][6][7] It also attenuates reperfusion arrhythmia [3][4][5]7 and recurrent atrial fibrillation. 28 In this study, ascorbic acid administration diminished MDA generation and myocardial damage after VF cardiac The HypoT, AA+NormoT, and AA+HypoT groups had significantly higher neurologic function scores than the NormoT group at the sixth, 24th, 48th, and 72nd hours following ROSC. No difference was noted among the AA+NormoT, HypoT, and AA+HypoT groups.…”
Section: Discussionmentioning
confidence: 52%
“…[3][4][5][6][7] It also attenuates reperfusion arrhythmia [3][4][5]7 and recurrent atrial fibrillation. 28 In this study, ascorbic acid administration diminished MDA generation and myocardial damage after VF cardiac The HypoT, AA+NormoT, and AA+HypoT groups had significantly higher neurologic function scores than the NormoT group at the sixth, 24th, 48th, and 72nd hours following ROSC. No difference was noted among the AA+NormoT, HypoT, and AA+HypoT groups.…”
Section: Discussionmentioning
confidence: 52%
“…Korantzopoulos et al [21] prospectively studied 44 patients following successful electrical cardioversion of persistent AF. The patients randomized into Vitamin C group and control group.…”
Section: Vitamin C and Ementioning
confidence: 99%
“…In a cohort study, LA diameter independently predicted cardiovascular events (nonfatal stroke, coronary heart disease, congestive heart failure, and fatal cardiovascular disease) after adjustment for established clinical, echocardiographic, and inflammatory risk factors [23]. Thus, LA dilatation identifies individuals at heightened risk who warrant aggressive risk factor modification.…”
Section: Discussionmentioning
confidence: 99%